在帕金森病中,增高的六基胺会导致神经元对病原体的反应升级
Luisa Franck1, Lisa Hahnefeld1,2, Lucie Valek1
1Goethe University Frankfurt, Faculty of Medicine, Institute of Clinical Pharmacology, Frankfurt am Main, Germany.
NPJ Parkinson's disease
|August 30, 2025
概括
在帕金森病 (PD) 模型中,葡萄糖胺 (GlcCer) 的升高表明脂质代谢受损. 这种积累,特别是GlcCer24:1,激活了感官神经元的先天免疫反应,导致PD病理.
科学领域:
- 神经科学
- 生物化学
- 免疫学
背景情况:
- 帕金森病 (PD) 的发病包括α-synuclein (αSyn) 的聚合.
- 与酸性葡萄糖酶 (GCase) 功能障碍相关的葡萄糖脂代谢受损促进了αSyn的形成.
- 葡萄糖胺 (GlcCer) 涉及到PD,但其确切的作用和积累模式需要进一步调查.
研究的目的:
- 研究葡萄糖胺 (GlcCer) 在各种帕金森病 (PD) 模型中的积累和影响.
- 探索GlcCer水平,αSyn病理和神经元反应之间的关系.
主要方法:
- 来自PD患者和小鼠模型的血和脑组织的脂质分析.
- 使用暴露于αSyn纤维的患者衍生纤维细胞和神经元细胞系的细胞研究.
- 用于分析对 GlcCer 的基因表达变化.
主要成果:
- 在PD患者中观察到血 GlcCer升高,特别是 GlcCer24:1,以及酸丁胆 (PC) 变化.
- 在PD小鼠大脑中发现GlcCer和硫酸盐 (SHexCer) 的增加;GlcCer在暴露于αSyn纤维的神经元中积累.
- GlcCer24:1 恶化了αSyn纤维的毒性,并诱导了感觉神经元中的糖脂反应基因,类似于病原体相关的信号.
结论:
- 在帕金森病中,细胞外GluCer水平升高.
- 累积的 GlcCer会触发感官神经元的先天免疫反应,可能会导致PD的进展.
- 葡萄糖代谢是PD的潜在治疗点.
更多相关视频
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.1K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.6K
相关概念视频
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
